Subscribe
Log In More

Log in via Institution
Log in via OpenAthens
Log in via BSG

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
Basket
Search More

Search for this keyword

Advanced search

Constipation

PTH-195 Lubiprostone Treatment Improves Constipation and Related Symptoms in Patients Refractory to other Constipation Therapies
R M Panas, T Joswick, P Lichtlen, D Panigrahi, R Ueno

Gut Jun 2013, 62 (Suppl 1) A291; DOI: 10.1136/gutjnl-2013-304907.682
PTH-198 Pooled Analysis of the most Frequent Adverse Events Associated with the use of Lubiprostone
T Joswick, G Dolecek, P Lichtlen, D Panigrahi, R Ueno

Gut Jun 2013, 62 (Suppl 1) A292; DOI: 10.1136/gutjnl-2013-304907.685
PTH-197 Long-Term Efficacy of Lubiprostone Demonstrated in Patients with Constipation Regardless of age, Gender or Race
T Joswick, G Dolecek, P Lichtlen, D Panigrahi, R Ueno

Gut Jun 2013, 62 (Suppl 1) A292; DOI: 10.1136/gutjnl-2013-304907.684
PTH-016 Defecating Scintigraphic Photography at St George’S Hospital: Review of Findings and Correlation with Patient Symptoms
R I Rusu, N Beharry, A Irwin, S Heenan, A Poullis

Gut Jun 2013, 62 (Suppl 1) A217-A218; DOI: 10.1136/gutjnl-2013-304907.504
PTH-022 Rectal Irrigation in Functional Bowel Symptoms: Prospective Audit of Patients Attending a Novel Tertiary Service (The Healthy Bowel Clinic)
S Blythin, C Molyneux, K Bodger, P Skaife

Gut Jun 2013, 62 (Suppl 1) A220; DOI: 10.1136/gutjnl-2013-304907.510
PWE-153 Association Between Constipation and Colorectal Cancer: Systematic Review and Meta-Analysis of Observational Studies
A M Power, N J Talley, A C Ford

Gut Jun 2013, 62 (Suppl 1) A193; DOI: 10.1136/gutjnl-2013-304907.441
PWE-025 Assessing the Percent of Days Linaclotide Improved Abdominal Symptoms and Stool Frequency in Patients with Irritable Bowel Syndrome with Constipation (IBS-C): Pooled Analysis of 2 Phase 3 Trials
S S Rao, L Chang, X Hao, B Lavins, S J Shiff, X Cao, H Schneier, M Currie, J Johnston

Gut Jun 2013, 62 (Suppl 1) A139-A140; DOI: 10.1136/gutjnl-2013-304907.314
PWE-026 Effects of 26 Weeks of Linaclotide Treatment on Adequate Relief and IBS Severity in Patients with Irritable Bowel Syndrome with Constipation (IBS-C)
E M Quigley, W D Chey, B Lavins, M Baird, D Fitch, X Hao, K Shi, M Currie, H Schneier, J Johnston

Gut Jun 2013, 62 (Suppl 1) A140-A141; DOI: 10.1136/gutjnl-2013-304907.315
PWE-027 Mediation Analysis Supports a Direct Effect of Linaclotide (LIN) on Abdominal Pain (AP) Relief Independent of Constipation Improvement
J MacDougall, D Mackinnon, B Lavins, A Lembo, S J Shiff, X Hao, M Currie, J Johnston

Gut Jun 2013, 62 (Suppl 1) A141; DOI: 10.1136/gutjnl-2013-304907.316
PWE-028 Significantly Improved Abdominal Pain (AP) with Linaclotide (LIN) vs Placebo (PBO) in Patients (PTS) with Irritable Bowel Syndrome (IBS) Regardless of Baseline Pain Severity in 2 Phase 3 Trials
J Johnston, W D Chey, B Lavins, S J Shiff, C Kurtz, J MacDougall, X Jia, H Schneier, M Currie

Gut Jun 2013, 62 (Suppl 1) A141-A142; DOI: 10.1136/gutjnl-2013-304907.317

Pages